ArticleArthroplasty (London, England)2026
Key determinants for lowering the risk of joint replacement in weight-bearing joints: a population-based cohort study.
Article in Arthroplasty (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHip and knee replacement (arthroplasty) is used to treat advanced joint disease by reducing pain and restoring joint function. This study aimed to identify determinants associated with a lower risk of joint replacement (JR).
methodsLongitudinal data from the Geelong Osteoporosis Study (GOS) were used. JR was identified via linkage with the Barwon Joint Registry, medical records, and self-report. Anthropometry, body composition, and blood biomarkers were obtained. Demographics, lifestyle, and comorbidities were self-reported. Fractures were identified from radiological reports. Participants with JR before baseline were excluded, leaving 2,882 eligible participants (1,436 men, 1,446 women; ages 20-96 years). A time-dependent Cox regression model with age as the primary time scale and sex as a stratification variable was fitted. Forward stepwise and the least absolute shrinkage and selection operator (LASSO) regression identified relevant predictors.
resultsOver a median follow-up of 16.7 years (IQR: 9.7-23.2), 223 participants (7.7%) underwent JR. Factors with the reduced risk of JR included lower body mass index (HR 0.96, 95% CI, 0.94-0.99), lower spine bone mineral density (BMD) (0.84, 0.77-0.92), lower procollagen type 1 N-terminal propeptide (0.69, 0.50-0.96), non-fallers (0.74, 0.55-0.99) and no history of cancer (0.66, 0.48-0.90). Lower dietary calcium intake (0.74, 0.52-1.04) was associated with the reduced risk of JR in the main models, but this association was attenuated after accounting for supplement use. Compared with low socioeconomic status (SES), participants with medium and high SES had higher JR risk (1.91, 1.04-3.50; 1.88, 1.13-3.15), although the association was weaker in women (interaction: 0.48, 0.25-0.91).
conclusionAge-related spine degeneration may explain the link between higher spine BMD and JR. The association between lower dietary calcium intake and reduced JR risk is likely driven by confounding by indication or reverse causality. Lower BMI and lower P1NP levels emerged as potentially modifiable pathways. The absence of falls and no history of cancer were associated with reduced JR risk; however, the cancer association was attenuated in the Fine-Gray analysis when competing mortality was accounted for, and the fall association should be interpreted as observational rather than as evidence of a modifiable pathway. Socioeconomic disparities also highlight potential avenues for reducing JR risk. Overall, these findings suggest that biological, lifestyle, and social determinants may play important roles in shaping long-term JR outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.